207 related articles for article (PubMed ID: 18227072)
1. The Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family: a Caenorhabditis elegans model of type I tyrosinemia.
Fisher AL; Page KE; Lithgow GJ; Nash L
J Biol Chem; 2008 Apr; 283(14):9127-35. PubMed ID: 18227072
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1.
Bergeron A; D'Astous M; Timm DE; Tanguay RM
J Biol Chem; 2001 May; 276(18):15225-31. PubMed ID: 11278491
[TBL] [Abstract][Full Text] [Related]
3. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.
Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L
J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091
[TBL] [Abstract][Full Text] [Related]
4. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
Morrow G; Angileri F; Tanguay RM
Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Aponte JL; Sega GA; Hauser LJ; Dhar MS; Withrow CM; Carpenter DA; Rinchik EM; Culiat CT; Johnson DK
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):641-5. PubMed ID: 11209059
[TBL] [Abstract][Full Text] [Related]
6. Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation.
Colemonts-Vroninks H; Neuckermans J; Marcelis L; Claes P; Branson S; Casimir G; Goyens P; Martens GA; Vanhaecke T; De Kock J
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375092
[TBL] [Abstract][Full Text] [Related]
7. The C. elegans lethal gut-obstructed gob-1 gene is trehalose-6-phosphate phosphatase.
Kormish JD; McGhee JD
Dev Biol; 2005 Nov; 287(1):35-47. PubMed ID: 16197937
[TBL] [Abstract][Full Text] [Related]
8. TATN-1 mutations reveal a novel role for tyrosine as a metabolic signal that influences developmental decisions and longevity in Caenorhabditis elegans.
Ferguson AA; Roy S; Kormanik KN; Kim Y; Dumas KJ; Ritov VB; Matern D; Hu PJ; Fisher AL
PLoS Genet; 2013; 9(12):e1004020. PubMed ID: 24385923
[TBL] [Abstract][Full Text] [Related]
9. The genetic tyrosinemias.
Scott CR
Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):121-6. PubMed ID: 16602095
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I.
Gil-Martínez J; Macias I; Unione L; Bernardo-Seisdedos G; Lopitz-Otsoa F; Fernandez-Ramos D; Lain A; Sanz-Parra A; Mato JM; Millet O
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670179
[TBL] [Abstract][Full Text] [Related]
11. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
[TBL] [Abstract][Full Text] [Related]
12. Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate.
Macias I; Laín A; Bernardo-Seisdedos G; Gil D; Gonzalez E; Falcon-Perez JM; Millet O
J Biol Chem; 2019 Aug; 294(35):13051-13060. PubMed ID: 31300554
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant.
Ibarra-González I; Fernández-Lainez C; Alcántara-Ortigoza MA; González-Del Angel A; Fernández-Henández L; Guillén-López S; Belmont-Martínez L; López-Mejía L; Varela-Fascinetto G; Vela-Amieva M
Mol Genet Genomic Med; 2019 Dec; 7(12):e937. PubMed ID: 31568711
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing
Ipson BR; Green RA; Wilson JT; Watson JN; Faull KF; Fisher AL
J Biol Chem; 2019 Jun; 294(24):9536-9554. PubMed ID: 31043480
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.
Morrow G; Tanguay RM
Adv Exp Med Biol; 2017; 959():9-21. PubMed ID: 28755181
[TBL] [Abstract][Full Text] [Related]
16. Loss of LIN-35, the Caenorhabditis elegans ortholog of the tumor suppressor p105Rb, results in enhanced RNA interference.
Lehner B; Calixto A; Crombie C; Tischler J; Fortunato A; Chalfie M; Fraser AG
Genome Biol; 2006; 7(1):R4. PubMed ID: 16507136
[TBL] [Abstract][Full Text] [Related]
17. Splicing mutations, mainly IVS6-1(G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients.
Arranz JA; Piñol F; Kozak L; Pérez-Cerdá C; Cormand B; Ugarte M; Riudor E
Hum Mutat; 2002 Sep; 20(3):180-8. PubMed ID: 12203990
[TBL] [Abstract][Full Text] [Related]
18. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice.
Sun MS; Hattori S; Kubo S; Awata H; Matsuda I; Endo F
J Am Soc Nephrol; 2000 Feb; 11(2):291-300. PubMed ID: 10665936
[TBL] [Abstract][Full Text] [Related]
19. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P
J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766
[TBL] [Abstract][Full Text] [Related]
20. An Alternative STAT Signaling Pathway Acts in Viral Immunity in
Tanguy M; Véron L; Stempor P; Ahringer J; Sarkies P; Miska EA
mBio; 2017 Sep; 8(5):. PubMed ID: 28874466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]